Potassium Chloride for Oral Solution

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Potassium Chloride for Oral Solution
Generic name: POTASSIUM CHLORIDE FOR ORAL SOLUTION
Manufacturer: Marlex Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 3e78028d-21a0-ba0f-e063-6294a90aac49
SPL ID: 3e780042-e8cd-95fc-e063-6294a90aa28a
Version: 1
Effective date: 2025-08-01
Source export date: 2026-10-27
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:13:49

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 16 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	212183	derived:openfda.application_number
application number		ANDA212183	openfda.application_number
brand name		Potassium Chloride for Oral Solution	openfda.brand_name
generic name		POTASSIUM CHLORIDE FOR ORAL SOLUTION	openfda.generic_name
manufacturer name		Marlex Pharmaceuticals Inc	openfda.manufacturer_name
ndc	package	10135-819-08	openfda.package_ndc
ndc	package	10135-820-08	openfda.package_ndc
ndc	product	10135-819	openfda.product_ndc
ndc	product	10135-820	openfda.product_ndc
ndc11	package	10135082008	derived:openfda.package_ndc
ndc11	package	10135081908	derived:openfda.package_ndc
rxcui		314182	openfda.rxcui
rxcui		312515	openfda.rxcui
spl id		3e780042-e8cd-95fc-e063-6294a90aa28a	id
spl set id		3e78028d-21a0-ba0f-e063-6294a90aac49	set_id
unii		660YQ98I10	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS . • Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation if administered undiluted. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [ see Dosage and Administration (2.1)].

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Marlex Pharmaceuticals at 1-888-582-1953 or drugsafety@marlexpharm.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.